Toggle navigation
Home
Search
Services
Blog
Contact
About
Organoplatinum Antitumor Drugs
Faltynek, Robert A.
University of the Sciences Philadelphia, Philadelphia, PA, United States
Search grants from Robert Faltynek
Search grants from University of the Sciences Philadelphia
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Radioimmunoassay/Biomarkers Core
Risperidone Subcutaneous Implant
Development of an in vivo screening technology for cancer vaccine immunogens
Mechanisms of Neuronal Guidance
Biomedical Research Support
Recently added grants:
Development of large-field-of-view hyperpolarized MRI
TCR engineering of human T cells for immunotherapy of hepatocellular carcinoma
Immuno-inflammatory Response Non-coding RNAs as Predictors of HPV Status & Outcome of Oropharyngeal Cancer Patients
Achieving smoking cessation milestones in opioid treatment patients: a randomized 2 x 2 factorial trial of directly observed and long-term varenicline
Allosteric inhibitors targeting oncogenic BRAF V600E dimers
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Academic Research Enhancement Awards (AREA) (R15)
Project #
1R15CA063594-01
Application #
2105550
Study Section
Medicinal Chemistry Study Section (MCHA)
Project Start
1994-07-15
Project End
1997-06-30
Budget Start
1994-07-15
Budget End
1997-06-30
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Institution
Name
University of the Sciences Philadelphia
Department
Chemistry
Type
Schools of Pharmacy
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Comments
Be the first to comment on Robert Faltynek's grant